FDA to 'institutionalize' compounding regulation to 'protect consumers'

In-PharmaTechnologist.com-Jun 19, 2019

The US FDA is set to center its drug compounding regulatory program in an office focused on stopping poor quality, unsafe and ineffective drugs reaching 

FDA's overreach will harm compounding pharmacies and the patients ...

STAT-Jun 19, 2019

But the FDA has overreached in implementing the provisions, all but halting common compounding practices that have been safely performed for years and on

CVS Lawsuit Gives a Revealing Look at Amazon's Pharmacy Ambitions

TheStreet.com-5 hours ago

Details of the proceeding suggest that the competition between Amazon and CVS -- along with other pharmacy benefit managers (PBMs) involved in dispensing ...

CVS just laid out a big reason why health companies are worried ...
CNBC-4 hours ago

View all